Combined inhibition of CDK4/6 and AKT is effective in Rb-intact triple-negative breast cancer of the luminal androgen receptor (LAR) subtypeGun Min Kim,Kyung-min Lee,Dhivya Sudhan,Albert Lin,Arnaldo Marin,Sumanta Chatterjee,Dan Ye,Vishal Kandagatla,Saurabh Mendiratta,Ariella Hanker,Carlos ArteagaCANCER RESEARCH(2022)引用 0|浏览11暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要